540 related items for PubMed ID: 17530506
1. Survival among COPD patients using fluticasone/salmeterol in combination versus other inhaled steroids and bronchodilators alone.
Mapel DW, Nelson LS, Lydick E, Soriano J, Yood MU, Davis KJ.
COPD; 2007 Jun; 4(2):127-34. PubMed ID: 17530506
[Abstract] [Full Text] [Related]
2. Survival of COPD patients using inhaled corticosteroids and long-acting beta agonists.
Mapel DW, Hurley JS, Roblin D, Roberts M, Davis KJ, Schreiner R, Frost FJ.
Respir Med; 2006 Apr; 100(4):595-609. PubMed ID: 16199151
[Abstract] [Full Text] [Related]
3. Effects of inhaled corticosteroids in monotherapy or combined with long-acting {beta}2-agonists on mortality among patients with chronic obstructive pulmonary disease.
Cyr MC, Beauchesne MF, Lemière C, Aaron SD, Blais L.
Ann Pharmacother; 2010 Apr; 44(4):613-22. PubMed ID: 20233915
[Abstract] [Full Text] [Related]
4. Association between incidence of acute exacerbation and medication therapy in patients with COPD.
Suh DC, Lau H, La HO, Choi IS, Geba GP.
Curr Med Res Opin; 2010 Feb; 26(2):297-306. PubMed ID: 19961283
[Abstract] [Full Text] [Related]
5. Inhaled corticosteroids and risk of lung cancer among COPD patients who quit smoking.
Kiri VA, Fabbri LM, Davis KJ, Soriano JB.
Respir Med; 2009 Jan; 103(1):85-90. PubMed ID: 18793832
[Abstract] [Full Text] [Related]
6. Withdrawal of fluticasone propionate from combined salmeterol/fluticasone treatment in patients with COPD causes immediate and sustained disease deterioration: a randomised controlled trial.
Wouters EF, Postma DS, Fokkens B, Hop WC, Prins J, Kuipers AF, Pasma HR, Hensing CA, Creutzberg EC, COSMIC (COPD and Seretide: a Multi-Center Intervention and Characterization) Study Group.
Thorax; 2005 Jun; 60(6):480-7. PubMed ID: 15923248
[Abstract] [Full Text] [Related]
7. Combined corticosteroid and long-acting beta(2)-agonist in one inhaler versus long-acting beta(2)-agonists for chronic obstructive pulmonary disease.
Nannini LJ, Lasserson TJ, Poole P.
Cochrane Database Syst Rev; 2012 Sep 12; 2012(9):CD006829. PubMed ID: 22972099
[Abstract] [Full Text] [Related]
8. A double-blind crossover study comparing the safety and efficacy of three weeks of Flu/Sal 250/50 bid plus albuterol 180 ug prn q4 hours to Flu/Sal 250/50 bid plus albuterol/Ipratropium bromide 2 puffs prn q4 hours in patients with chronic obstructive pulmonary disease.
Balkissoon R, Make B.
COPD; 2008 Aug 12; 5(4):221-7. PubMed ID: 18671147
[Abstract] [Full Text] [Related]
9. Enhanced persistence with tiotropium compared with other respiratory drugs in COPD.
Breekveldt-Postma NS, Koerselman J, Erkens JA, Lammers JW, Herings RM.
Respir Med; 2007 Jul 12; 101(7):1398-405. PubMed ID: 17368011
[Abstract] [Full Text] [Related]
10. Economic assessment of initial maintenance therapy for chronic obstructive pulmonary disease.
Akazawa M, Hayflinger DC, Stanford RH, Blanchette CM.
Am J Manag Care; 2008 Jul 12; 14(7):438-48. PubMed ID: 18611095
[Abstract] [Full Text] [Related]
11. Mono- and combination therapy of long-acting bronchodilators and inhaled corticosteroids in advanced COPD.
Ohar JA, Donohue JF.
Semin Respir Crit Care Med; 2010 Jun 12; 31(3):321-33. PubMed ID: 20496301
[Abstract] [Full Text] [Related]
12. Inhaled corticosteroids are more effective in COPD patients when used with LABA than with SABA.
Kiri VA, Bettoncelli G, Testi R, Viegi G.
Respir Med; 2005 Sep 12; 99(9):1115-24. PubMed ID: 15921904
[Abstract] [Full Text] [Related]
13. Economic evaluation of treating chronic obstructive pulmonary disease with inhaled corticosteroids and long-acting beta2-agonists in a health maintenance organization.
Gagnon YM, Levy AR, Spencer MD, Hurley JS, Frost FJ, Mapel DW, Briggs AH.
Respir Med; 2005 Dec 12; 99(12):1534-45. PubMed ID: 16291076
[Abstract] [Full Text] [Related]
14. Adding long-acting beta-agonists to inhaled corticosteroids after discharge from the emergency department for acute asthma: a randomized controlled trial.
Rowe BH, Wong E, Blitz S, Diner B, Mackey D, Ross S, Senthilselvan A.
Acad Emerg Med; 2007 Oct 12; 14(10):833-40. PubMed ID: 17898245
[Abstract] [Full Text] [Related]
15. Benefits and risks of adjunctive inhaled corticosteroids in chronic obstructive pulmonary disease: a meta-analysis.
Sobieraj DM, White CM, Coleman CI.
Clin Ther; 2008 Aug 12; 30(8):1416-25. PubMed ID: 18803985
[Abstract] [Full Text] [Related]
16. Combination of budesonide/formoterol more effective than fluticasone/salmeterol in preventing exacerbations in chronic obstructive pulmonary disease: the PATHOS study.
Larsson K, Janson C, Lisspers K, Jørgensen L, Stratelis G, Telg G, Ställberg B, Johansson G.
J Intern Med; 2013 Jun 12; 273(6):584-94. PubMed ID: 23495860
[Abstract] [Full Text] [Related]
17. [Inhaled corticosteroids in patients with COPD: maintain current guidelines].
Heijdra YF.
Ned Tijdschr Geneeskd; 2007 Oct 06; 151(40):2195-7. PubMed ID: 17969568
[Abstract] [Full Text] [Related]
18. Advair: combination treatment with fluticasone propionate/salmeterol in the treatment of asthma.
Nelson HS.
J Allergy Clin Immunol; 2001 Feb 06; 107(2):398-416. PubMed ID: 11174215
[Abstract] [Full Text] [Related]
19. Short-acting beta 2-agonist and oral corticosteroid use in asthma patients prescribed either concurrent beclomethasone and long-acting beta 2-agonist or salmeterol/fluticasone propionate combination.
Angus R, Reagon R, Cheesbrough A.
Int J Clin Pract; 2005 Feb 06; 59(2):156-62. PubMed ID: 15854190
[Abstract] [Full Text] [Related]
20. Association between previous health care use and initiation of inhaled corticosteroid and long-acting beta2-adrenergic agonist combination therapy among US patients with asthma.
Blanchette CM, Culler SD, Ershoff D, Gutierrez B.
Clin Ther; 2009 Nov 06; 31(11):2574-83. PubMed ID: 20110003
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
